| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 4 |
| 1 | ADALIMUMAB-AATY | 4 |
| 2 | ADALIMUMAB-ADAZ | 4 |
| 3 | ADALIMUMAB-FKJP | 4 |
| 4 | OLMESARTAN MEDOXOMIL | 3 |
| 5 | PREDNISONE | 3 |
| 6 | DUPILUMAB | 2 |
| 7 | EFAVIRENZ | 2 |
| 8 | LAMIVUDINE | 2 |
| 9 | LAMIVUDINE ORAL | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RITLECITINIB | 1 | 0.0005 |
| 1 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 2 | 0.0002 |
| 2 | RIPRETINIB | 1 | 0.0002 |
| 3 | EFAVIRENZ | 2 | 0.0002 |
| 4 | BENZOYL PEROXIDE | 1 | 0.0001 |
| 5 | PEGVALIASE-PQPZ | 1 | 0.0001 |
| 6 | DASATINIB | 1 | 0.0001 |
| 7 | ADALIMUMAB-FKJP | 4 | 0.0001 |
| 8 | OLMESARTAN MEDOXOMIL | 3 | 0.0001 |
| 9 | ADALIMUMAB-AATY | 4 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Phenylalanine Metabolizing Enzyme [EPC] | 1 | 0.0001 |
| 1 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0001 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 3 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 4 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 5 | Interleukin-6 Receptor Antagonist [EPC] | 2 | 0.0000 |
| 6 | Purine Antimetabolite [EPC] | 1 | 0.0000 |
| 7 | Azole Antifungal [EPC] | 1 | 0.0000 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 5 | 0.0000 |
| 9 | Corticosteroid [EPC] | 6 | 0.0000 |